Q: Can you provide an overview of UQUIFA Group evolution as a leader in Contract Development and Manufacturing Organization (CDMO)/fine chemical manufacturing within Europe, highlighting key milestones and developments?
A: With over 87 years in the industry, the UQUIFA Group has evolved in terms of its product offering, business positioning and its own internal capabilities. In the recent past the acquisition of SONEAS enhanced our R&D and manufacturing capabilities in Hungary. We have transitioned from being a CMO (contract manufacturing organization) to a full integrated Contract Development and Manufacturing Organization (CDMO) serving key markets in the USA, Japan, and Europe. Notable milestones include integrating our facilities in Spain, Hungary, and Mexico, focusing on strategic investments in people, products, and plants through substantial CAPEX initiatives since 2022. We have expanded our services to include discovery capabilities even as we brought to commercialization certain proprietary expertise like metathesis, hydroxyethylation, and chromatographic purification for our customer base.

Q: How does UQUIFA G ... ...